Laboratory Investigation of Myeloproliferative Neoplasms (MPNs): Recommendations of the Canadian Mpn Group
| Autor: | Harold J. Olney, Jaroslav F. Prchal, Anna Porwit, Brian Leber, Suzanne Kamel-Reid, Vincent Éthier, Linda Foltz, Lambert Busque, Vikas Gupta, Shireen Sirhan, Radmila Day, Aly Karsan |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Pathology Canada Myeloproliferative Disorders Standardization Cost effectiveness business.industry Cost-Benefit Analysis Alternative medicine Foundation (evidence) General Medicine Diagnostic tools Laboratories Hospital 03 medical and health sciences 0302 clinical medicine Clinical research Therapeutic Area 030220 oncology & carcinogenesis Health care medicine Humans Medical physics business 030215 immunology |
| Zdroj: | American journal of clinical pathology. 146(4) |
| ISSN: | 1943-7722 |
| Popis: | Objectives: To standardize diagnostic investigations for myeloproliferative neoplasms (MPNs) to increase homogeneity in patient care and to streamline diagnostic approaches in the most efficient and cost-effective manner. Methods: The development of Canadian expert consensus recommendations for the diagnosis of MPNs began with a review of the following: clinical evidence, daily practice, existing treatment guidelines, and availability of diagnostic tools. Each group member was assigned a specific topic, which they discussed with the entire group during several consensus meetings. Results: This document provides the Canadian MPN group’s recommendations, proposed diagnostic algorithms, and background evidence upon which decisions were made. Conclusions: Standardization of diagnostic investigations will increase homogeneity in patient care and provide a foundation for future clinical research in this rapidly evolving therapeutic area. Streamlining diagnostic approaches in the most efficient and cost-effective manner will also result in significant cost saving for the health care system. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|